Production (Stage)
Diebold Nixdorf, Incorporated
DBD
$47.35
-$0.06-0.13%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.66% | -0.25% | 2.88% | 7.19% | 8.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.66% | -0.25% | 2.88% | 7.19% | 8.85% |
| Cost of Revenue | -4.98% | -2.81% | 1.51% | 7.68% | 8.20% |
| Gross Profit | 4.91% | 8.17% | 7.34% | 5.63% | 11.03% |
| SG&A Expenses | -5.72% | -9.50% | -13.36% | -16.37% | -4.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -268.75% | -176.92% | -- | -- | -- |
| Total Operating Expenses | -5.16% | -4.19% | -1.60% | 2.41% | 5.12% |
| Operating Income | 43.35% | 94.67% | 150.18% | 200.93% | 212.76% |
| Income Before Tax | -96.25% | -96.57% | -95.47% | 336.68% | 487.40% |
| Income Tax Expenses | 26.60% | -15.06% | -46.65% | 256.25% | -56.87% |
| Earnings from Continuing Operations | -100.54% | -101.05% | -99.83% | 318.50% | 387.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.67% | -300.00% | -162.07% | -139.02% | -139.47% |
| Net Income | -100.69% | -101.20% | -99.98% | 319.24% | 389.09% |
| EBIT | 43.35% | 94.67% | 150.18% | 200.93% | 212.76% |
| EBITDA | 26.25% | 54.96% | 73.41% | 101.88% | 88.45% |
| EPS Basic | -100.92% | -101.55% | -99.98% | 408.59% | 555.75% |
| Normalized Basic EPS | 321.36% | 999.66% | 333.08% | 265.93% | 150.35% |
| EPS Diluted | -100.95% | -101.59% | -100.00% | 405.21% | 549.24% |
| Normalized Diluted EPS | 320.10% | 1,002.47% | 333.10% | 265.81% | 150.46% |
| Average Basic Shares Outstanding | -29.11% | -40.75% | -49.08% | -46.53% | -32.97% |
| Average Diluted Shares Outstanding | -29.27% | -40.86% | -49.15% | -46.30% | -32.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |